Sonya Negley, IOM, CSMA, reviews how patient advocates can help patients newly diagnosed with metastatic breast cancer.
Sonya Negley, IOM, CSMA: I think the most important thing for patient advocates and patient advocacy organizations is to make sure that we have the correct, most recent data. The information about new treatment options coming to market can be overwhelming, and while it can be protracted, it also comes to market quickly. So, it’s important we as patient advocacy organizations have a good idea of what that means and what that means for the patients. The best thing individual patient advocates can do is get involved, and have a voice in what is going on with metastatic breast cancer.
For a lot of people who have cancer in general, most of their treatment options are pretty straightforward, and for the most part, their cancer can be contained or cured. But in metastatic breast cancer, that’s not where we are yet. We are at a point where there are a lot of discoveries happening, a lot of personalized medicine; however, it’s not a disease that is not terminal. It’s not chronic, it’s not curable. So, the best thing patient advocates can do is share their voice, share the importance of research. It is paramount that we fund research to make sure we can get to those good treatment options or treatment bridges, and hopefully soon, have a discovery that will render this disease survivable. Sharing stories of what they’ve gone through [is important]. Not necessarily saying to another patient that their journey equals the newly diagnosed journey, but rather, sharing their experiences so others can understand that you can have a good quality of life, and there are lessons [to be] learned from other patient advocates.
Transcript edited for clarity
Metabolic Syndrome, Obesity Contribute to Breast Cancer Mortality in Postmenopausal Women
May 13th 2024A large study finds that obesity and metabolic syndrome raise breast cancer mortality risk, but through different mechanisms. Metabolic syndrome is linked to a specific type of breast cancer, whereas obesity increases risk across all breast cancer subtypes.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Social Equity, Strong Health Care Systems Can Improve Advanced Breast Cancer Outcomes Globally
May 6th 2024Disparities in health care systems around the world limit access to effective treatments for advanced breast cancer, especially for people in low- and middle-income countries and marginalized communities. Stronger health systems and social education efforts are necessary to improve outcomes for all patients.
Read More
The Disproportionate Impact of the Pandemic on Health Care Disparities and Cancer
February 22nd 2022On this episode of Managed Care Cast, we discuss how already wide health care inequities in cancer are becoming much worse because of the COVID-19 pandemic, with guest Monica Soni, MD, associate chief medical officer at New Century Health.
Listen
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More